Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2500 of 2529 entries
View as:

Freedom Study: Myfortic in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00101738 Org: User:
Start: 03/31/03 End: 05/31/05 Due: 05/31/06

Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04676555 Org: User:
Start: 05/11/21 End: 10/21/21 Due: 10/21/22

Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00102388 Org: User:
Start: 01/31/05 End: - Due: -

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

Phase: N/A Priority: Normal
NCT ID: NCT03887520 Org: User:
Start: 11/27/18 End: 07/30/21 Due: 07/30/22

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

Phase: N/A Priority: Normal
NCT ID: NCT05611229 Org: User:
Start: 06/16/20 End: 12/03/21 Due: 12/03/22

Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00420615 Org: User:
Start: 12/31/06 End: - Due: -

Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01080768 Org: User:
Start: 02/28/10 End: 11/30/10 Due: 11/30/11

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02595970 Org: User:
Start: 05/20/15 End: 02/09/17 Due: 02/09/18

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05650060 Org: User:
Start: 01/20/21 End: 12/23/21 Due: 12/23/22

Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03087942 Org: User:
Start: 07/05/17 End: 08/07/18 Due: 08/07/19

A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02626234 Org: User:
Start: 12/08/15 End: 04/28/17 Due: 04/28/18

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT00235391 Org: User:
Start: 10/31/05 End: 10/31/08 Due: 10/31/09

A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02570854 Org: User:
Start: 09/22/15 End: 05/13/20 Due: 05/13/21

Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03828539 Org: User:
Start: 02/22/19 End: 07/29/20 Due: 07/29/21

Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00239005 Org: User:
Start: 09/30/05 End: - Due: -

A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149

Phase: N/A Priority: Normal
NCT ID: NCT01709903 Org: User:
Start: 11/30/12 End: 02/28/14 Due: 02/28/15

A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

Phase: N/A Priority: Normal
NCT ID: NCT01601600 Org: User:
Start: 01/31/12 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

Phase: N/A Priority: Normal
NCT ID: NCT00172016 Org: User:
Start: 01/31/04 End: - Due: -

Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

Phase: N/A Priority: Normal
NCT ID: NCT00281658 Org: User:
Start: 01/02/06 End: 11/23/21 Due: 11/23/22

A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants

Phase: N/A Priority: Normal
NCT ID: NCT04812548 Org: User:
Start: 05/31/21 End: 05/08/23 Due: 05/08/24

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Phase: N/A Priority: Normal
NCT ID: NCT00790400 Org: User:
Start: 04/30/09 End: 11/30/15 Due: 11/30/16

A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00750295 Org: User:
Start: 02/28/07 End: 01/31/08 Due: 01/31/09

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00825539 Org: User:
Start: 01/31/09 End: 11/30/11 Due: 11/30/12

Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02775916 Org: User:
Start: 06/01/16 End: 05/17/17 Due: 05/17/18

Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00487708 Org: User:
Start: 01/31/05 End: 07/31/08 Due: 07/31/09